1. Wang, Feng, Zhao, Miao, Jiang, Yuehong, Zhou, Dahong, Dong, Zipu. 2022. LncRNA UBE2R2-AS1, as prognostic marker, promotes cell proliferation and EMT in prostate cancer. In Histology and histopathology, 38, 637-645. doi:10.14670/HH-18-505. https://pubmed.ncbi.nlm.nih.gov/35916204/
2. Xu, Wu, Che, Dan-Dan, Chen, Liang, Liu, Qing, Pan, Ya-Wen. 2021. UBE2R2-AS1 Inhibits Xenograft Growth in Nude Mice and Correlates with a Positive Prognosis in Glioma. In Journal of molecular neuroscience : MN, 71, 1605-1613. doi:10.1007/s12031-021-01793-y. https://pubmed.ncbi.nlm.nih.gov/33528791/
3. Du, Yaoqiang, Li, Rusong, Fu, Danqing, Zhang, Wei, Chu, Lisheng. . Multi-omics technologies and molecular biomarkers in brain tumor-related epilepsy. In CNS neuroscience & therapeutics, 30, e14717. doi:10.1111/cns.14717. https://pubmed.ncbi.nlm.nih.gov/38641945/
4. Xu, Jie, Xiao, Meiqin, Huang, Zhijun, Chen, Zhiyao, Lin, Jianqing. 2023. UBE2R2-AS1, as a prognostic marker of gastric cancer, promotes the malignant phenotype of gastric cancer cells. In Histology and histopathology, 39, 739-745. doi:10.14670/HH-18-677. https://pubmed.ncbi.nlm.nih.gov/38009743/
5. Zhang, Yang, Li, Leyan, Tu, Yi, Cao, Yi, Li, Yong. . A DCS-related lncRNA signature predicts the prognosis and chemotherapeutic response of patients with gastric cancer. In Bioscience reports, 42, . doi:10.1042/BSR20220989. https://pubmed.ncbi.nlm.nih.gov/35993308/
6. Liu, Jie, Zhu, Guoguo, Xu, Siya, Lu, Qiping, Tang, Zhongzhi. 2017. Analysis of miRNA expression profiling in human umbilical vein endothelial cells affected by heat stress. In International journal of molecular medicine, 40, 1719-1730. doi:10.3892/ijmm.2017.3174. https://pubmed.ncbi.nlm.nih.gov/29039486/
7. Zou, Ruoyao, Xu, Haoya, Li, Feifei, Wang, Shengke, Zhu, Liancheng. 2020. Increased Expression of UBE2T Predicting Poor Survival of Epithelial Ovarian Cancer: Based on Comprehensive Analysis of UBE2s, Clinical Samples, and the GEO Database. In DNA and cell biology, 40, 36-60. doi:10.1089/dna.2020.5823. https://pubmed.ncbi.nlm.nih.gov/33180631/
8. Zhang, Liwei, Jin, Yue, Yang, Hao, Shi, Yongheng, Wang, Yu. . SMYD3 promotes epithelial ovarian cancer metastasis by downregulating p53 protein stability and promoting p53 ubiquitination. In Carcinogenesis, 40, 1492-1503. doi:10.1093/carcin/bgz078. https://pubmed.ncbi.nlm.nih.gov/31002112/